<DOC>
	<DOCNO>NCT00354159</DOCNO>
	<brief_summary>The purpose clinical research study evaluate safety effectiveness investigational implantable hemodynamic monitor ( IHM ) , IHM combination implantable cardioverter defibrillator ( ICD ) . The investigational IHM ability record report force heart pump blood ( heart pressure ) . When combined ICD , device additional ability send strong electrical impulse , shock , heart detect dangerously fast heartbeat return normal rhythm . The IHM IHM/ICD implant surgically skin upper chest area . This study also determine doctor use information relate heart pressure management heart failure .</brief_summary>
	<brief_title>Reducing Decompensation Events Utilizing Intracardiac Pressures Patients With Chronic Heart Failure ( HF ) ( REDUCEhf )</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Subjects heart failure sometimes interfere daily activity ( New York Heart Association [ NYHA ] Class II ( 1 ) ) subject heart failure severely limits daily activity ( NYHA Class III ( 2 ) ) baseline Subject appropriate medical therapy heart failure ( diuretic , angiotensinconverting enzyme ( ACE ) inhibitor angiotensin receptor blocker ( ARB ) beta blocker ) least three month prior baseline evaluation . Subject stable medication maximize subject 's tolerance ACE ARB beta blocker determine study investigator least 30 day prior baseline evaluation . ( Stable define 100 % increase 50 % decrease dose . ) If subject intolerant ACE , ARB beta blocker document evidence must available . Subject least one heart failurerelated hospitalization least one heart failurerelated emergency department urgent care visit necessitate heart failurerelated intravenous therapy ( e.g . diuretic administration ) within 12 month prior baseline evaluation To consider Chronicle ICD : Subject , risk , heart beat fast his/her doctor determine he/she need implantable cardioverter defibrillator ( ICD ) . 1 . Class II Subjects cardiac disease result slight limitation physical activity . They comfortable rest . Ordinary physical activity result fatigue , palpitation , dyspnea , angina . 2 . Class III Subjects cardiac disease result marked limitation physical activity . They comfortable rest . Less ordinary activity cause fatigue , palpitation , dyspnea , angina . Subjects severe heart failure always rest ( NYHA Class IV ( 3 ) ) Stage D ( 4 ) refractory heart failure . Subjects severe renal dysfunction . Subjects severe noncardiac condition limit 12month survival . Subjects concurrent study may confound result . ( 3 ) Class IV Subjects cardiac disease result inability carry physical activity without discomfort . Symptoms heart failure anginal syndrome may present even rest . If physical activity undertaken , discomfort increase . ( 4 ) Stage D refractory heart failure : Patients mark symptom rest despite maximal medical therapy ( e.g. , recurrently hospitalize safely discharged hospital without specialized intervention )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Implantable cardioverter defibrillator</keyword>
	<keyword>Intracardiac pressure</keyword>
</DOC>